ProCE Banner Activity

Expert Answers to Questions on PARP Inhibition for Prostate Cancer

Podcast Episodes
In this podcast episode, listen to Charles J. Ryan, MD, and Neal D. Shore, MD, FACS, as they answer questions from a healthcare professional audience on the use of PARP inhibitors and PARP inhibitor combinations for patients with prostate cancer.

Released: April 06, 2021

Expiration: April 05, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer TEXT Only

Faculty Disclosure

Primary Author

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California

Neal D. Shore, MD, FACS

Head of Genitourinary Oncology
START-CURC
Atlantic Urology Clinics Specialists
Myrtle Beach, South Carolina